Indices Grind Highe...
Health Care: Health Services
Bio-Reference Labs Inc. (BRLI: NASDAQ)
$19.37 -0.64 | -3.20%
02/09/12 - 03:45 PM ET
254.75K / 607.10K
Vol / Avg. Vol:20.15 / 20.01
Open / Prev. Close:19.36 - 20.15
Today's Range:11.41 - 25.99
52 Wk Range:22.99%
Performance YTD:TheStreet Rating:
Portfolios with BRLI
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorSmall-Caps With Big Potential
- UserSPECULATIVE
- ContributorEarnings Short Squeeze Play...
- ContributorThree Growth Stocks for a B...
- UserRFW2
- ContributorTop 5 Small-Cap Stocks: Aug...
- UserSmall stocks
Latest BRLI Headlines from TheStreet
- Bio-Reference Labs Inc. Stock Upgraded (BRLI) 02.01.12 | 06:02 am
- Bio-Reference Labs Inc. Stock Downgraded (BRLI) 11.28.11 | 05:11 am
- Bio-Reference Rises On Unusually High Volume (BRLI) 11.08.11 | 01:11 pm
- Bio-References Not Done Growing, Says CEO
09.09.11 | 05:09 am - 5 Earnings Short-Squeeze Plays 08.23.11 | 01:08 pm
- Bio-Reference Reaches New 52-Week High (BRLI) 05.26.11 | 10:05 am
- Heavily Shorted Stocks That Could Pop on Earnings 05.24.11 | 07:05 am
- Bio-Reference Stock Hits New 52-Week High (BRLI) 04.28.11 | 04:04 pm
- Guru-based Investing, Munis and Madison, Oil and the Economy 02.24.11 | 04:02 pm
- Stock Wrap: The Real Story, Feb 24 02.24.11 | 04:02 pm
Press Releases for BRLI
- BioReference Announces 2012 Annual Meeting Date - Business Wire 02.08.12 | 03:02 pm
- BioReference To Launch Groundbreaking Solid Tumor Genotyping Test Through Its GenPath Oncology Laboratory - Business Wire 01.26.12 | 08:01 am
- BioReference Laboratories, Inc. Announces Contract With Corizon, Inc. To Provide Correctional Healthcare Laboratory Services - Business Wire 01.12.12 | 08:01 am
- Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings And Cash Flow For Fourth Quarter And Full Fiscal Year - Business Wire 12.08.11 | 08:12 am
- BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2011 - Business Wire 12.07.11 | 02:12 pm
- BioReference Laboratories, Inc. To Speak At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.07.11 | 08:12 am
- Bio-Reference Laboratories, Inc. And McKesson Specialty Health’s Onmark GPO Execute Purchasing Agreement - Business Wire 11.22.11 | 02:11 pm
- Bio-Reference Laboratories’ CEO Marc Grodman MD Speaks At Capitol Hill Policy Forum On The Contribution Genetic Tests Are Making To Cancer Care - Business Wire 11.18.11 | 11:11 am
- Bio-Reference Laboratories Named 8th Fastest Growing Company In State Of New Jersey - Business Wire 11.15.11 | 08:11 am
- Bio-Reference Laboratories, Inc. Announces Stock Buy-Back Plan - Business Wire 11.11.11 | 02:11 pm
Partner Headlines for BRLI
- 10 Highly Shorted, Rallying Stocks With Strong Sources Of Profitability - Seeking Alpha 02.02.12 | 08:02 am
- Bio-Reference: Loads Of Dirty Laundry - Seeking Alpha 11.13.11 | 09:11 am
- Jefferies Places Bio-References Labs Under Review - Benzinga 11.11.11 | 09:11 am
- UPDATE: StreetSweeper Posts Negative Article on Bio-Reference - Benzinga 11.10.11 | 01:11 pm
- Questions Raised Over Bio-Reference Labs - Benzinga 11.01.11 | 01:11 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Upgrades, Downgrades, Initiations and Other Changes for Friday - Seeking Alpha 05.27.11 | 04:05 pm
- 10 Health Care Companies You Can Be Proud to Own - Benzinga 04.08.11 | 06:04 pm
- Benzinga’s Volume Movers (MNTA, HAIN, BRLI, PAAS) - Benzinga 08.26.10 | 01:08 pm
- UPDATE 1-Bio-Reference Labs results top market - Reuters 05.27.10 | 10:05 am
